Sixth Annual Pediatric Cancer Symposium Tumor Microenvironment 2019
Target Audience
Pediatricians, Family Practice Physicians, Nurse Practitioners and Physician Assistants.
Learning Objectives
After this conference the participants will be able to:
- Describe tumor microenvironment and gain a better understanding.
- Discuss current targets/pathways that are being investigated in tumor microenvironment.
Activity Director: Michael Burke, MD
Planning Committee:
- Michael Burke, MD
- Subramaniam Malarkannan, PhD
- Jeffrey Medin, PhD
- Cindy Schwartz, MD, MPH
- Julie Talano, MD
Speakers:
- Michael Burke, MD
- Timothy Cripe, MD, PhD, FAAP
- Rama Khokha, PhD
- Besim Ogretmen, PhD
- Keri Schadler, PhD
- Elizabeth Beierle, MD
All persons in control of content have NO relevant financial relationships to disclose except the following person(s):
Name | Company | Roles |
Michael Burke, MD (Presenter) | Amgen Pharmaceuticals Jazz Pharmaceuticals Servier Pharmaceutical | Speaker Speaker Speaker |
Jeff Medin, PhD (Planner) | Sanofi Genzyme Shire Rapa Therapeutics AVROBIO | Speaker |
In accordance with the ACME Standards for Commercial Support Number 6, all in control of content disclosed any relevant financial relationships. These relationships were reviewed via the MCW conflict of interest resolution process and resolved
The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Medical College of Wisconsin designates this live activity for a maximum of 5.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The Medical College of Wisconsin designates this activity for up to 5.0 hours of participation for continuing education for allied health professionals.
Available Credit
- 5.00 AMA PRA Category 1 Credit(s)™AMA PRA Category 1 Credit(s)™
- 5.00 Hours of ParticipationHours of Participation credit.